Bringing the fundamentals into focus…
Back to ANI Pharmaceuticals, Inc.
How ANI Pharmaceuticals, Inc. stacks up
ANIP · against 432 other Healthcare companies of similar size
Profitability
85/ 100
Near the top of its peers.
Ranked #68 of 433 · scores higher than 84% of peers
Bars: peers in each 10-point band of the profitability score40 peers with a profitability score of 80–89, including ANIP · Click a bar to see the companies
Why profitability scores 85?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on invested capital, return on assets and operating margin, which are stronger than most Healthcare peers.
- a wider operating margin: stronger than 72% of peers. Operating margin: 15.4% vs peer median 7.1%
- a higher return on assets: stronger than 83% of peers. Return on assets: 7.2% vs peer median 1.7%
- a higher return on invested capital: stronger than 88% of peers. Return on invested capital: 22.1% vs peer median 4.7%
Metric by metric
Position: dot = ANIP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ANIP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 408 reported | 22.1% | 5.4% | 86% | 33% | |
| Operating marginHigher is better · 404 reported | 15.4% | 7.1% | 74% | 33% | |
| Return on assetsHigher is better · 417 reported | 7.2% | 1.9% | 83% | 33% | |
| Return on equityHigher is better · 401 reported | 20.5% | 4.3% | 91% | Context only | |
| Gross marginHigher is better · 448 reported | 60.4% | 47.3% | 67% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ANIP| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 66 | 18.3B DKK (≈$2.7B) | 86 | 81 | |
| 68 | 7.2B CNY (≈$1.0B) | 85 | 69 | |
| 68 | 16.5B CNY (≈$2.3B) | 85 | 57 | |
| 68 | 22.4B CNY (≈$3.1B) | 85 | 62 | |
| 68 | 1.7B USD | 85 | 77 | |
| 72 | 168.6B INR (≈$2.0B) | 84 | 63 | |
| 72 | 73.5B TRY (≈$2.2B) | 84 | 68 | |
| 72 | 142.5B INR (≈$1.7B) | 84 | 71 | |
| 75 | 226.3B JPY (≈$1.5B) | 83 | 77 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score